- Home
- CPHI vs CARM Comparison
CPHI vs CARM Comparison
Compare CPHI & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHI
- CARM
- Stock Information
- Founded
- CPHI N/A
- CARM 2016
- Country
- CPHI China
- CARM United States
- Employees
- CPHI N/A
- CARM N/A
- Industry
- CPHI Biotechnology: Pharmaceutical Preparations
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- CPHI Health Care
- CARM Health Care
- Exchange
- CPHI Nasdaq
- CARM Nasdaq
- Market Cap
- CPHI 7.3M
- CARM 8.4M
- IPO Year
- CPHI N/A
- CARM N/A
- Fundamental
- Price
- CPHI N/A
- CARM $0.41
- Analyst Decision
- CPHI
- CARM Hold
- Analyst Count
- CPHI 0
- CARM 5
- Target Price
- CPHI N/A
- CARM $0.90
- AVG Volume (30 Days)
- CPHI 158.3K
- CARM 42.2M
- Earning Date
- CPHI 08-13-2025
- CARM 08-07-2025
- Dividend Yield
- CPHI N/A
- CARM N/A
- EPS Growth
- CPHI N/A
- CARM N/A
- EPS
- CPHI N/A
- CARM N/A
- Revenue
- CPHI $4,295,377.00
- CARM $19,964,000.00
- Revenue This Year
- CPHI N/A
- CARM N/A
- Revenue Next Year
- CPHI N/A
- CARM N/A
- P/E Ratio
- CPHI N/A
- CARM N/A
- Revenue Growth
- CPHI N/A
- CARM 32.45
- 52 Week Low
- CPHI $1.20
- CARM $0.14
- 52 Week High
- CPHI $3.35
- CARM $1.42
- Technical
- Relative Strength Index (RSI)
- CPHI 52.73
- CARM 51.65
- Support Level
- CPHI $1.70
- CARM $0.37
- Resistance Level
- CPHI $1.91
- CARM $0.44
- Average True Range (ATR)
- CPHI 0.18
- CARM 0.07
- MACD
- CPHI 0.03
- CARM -0.01
- Stochastic Oscillator
- CPHI 59.62
- CARM 10.37
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.